| Year |
Citation |
Score |
| 2019 |
Kern-Goldberger AS, Hill-Ricciuti AC, Zhou JJ, Savant AP, Rugg L, Dozor AJ, Welter J, Saiman L, Quittell LM. Perceptions of safety monitoring in CF clinical studies and potential impact on future study participation. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31151855 DOI: 10.1016/J.Jcf.2019.05.001 |
0.309 |
|
| 2019 |
Cios K, Cohen B, Quittell LM, Liu J, Larson EL. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis. American Journal of Infection Control. PMID 30732978 DOI: 10.1016/J.Ajic.2018.12.021 |
0.362 |
|
| 2012 |
Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, Angst D, Cabana M, Saiman L. Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families. Pediatric Pulmonology. 47: 144-52. PMID 22241572 DOI: 10.1002/Ppul.21528 |
0.354 |
|
| 2010 |
Flume PA, Mogayzel PJ, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. American Journal of Respiratory and Critical Care Medicine. 182: 298-306. PMID 20675678 DOI: 10.1164/Rccm.201002-0157Oc |
0.424 |
|
| 2010 |
Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatric Pulmonology. 45: 157-64. PMID 20054860 DOI: 10.1002/Ppul.21164 |
0.316 |
|
| 2009 |
Stone A, Quittell L, Zhou J, Alba L, Bhat M, DeCelie-Germana J, Rajan S, Bonitz L, Welter JJ, Dozor AJ, Gherson I, Lowy FD, Saiman L. Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts. The Pediatric Infectious Disease Journal. 28: 895-9. PMID 20135845 DOI: 10.1097/Inf.0B013E3181A3Ad0A |
0.365 |
|
| 2009 |
Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 136: 1554-60. PMID 19505987 DOI: 10.1378/Chest.09-0132 |
0.421 |
|
| 2007 |
Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. American Journal of Respiratory and Critical Care Medicine. 176: 957-69. PMID 17761616 DOI: 10.1164/Rccm.200705-664Oc |
0.367 |
|
| 2007 |
LeGrys VA, Yankaskas JR, Quittell LM, Marshall BC, Mogayzel PJ. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. The Journal of Pediatrics. 151: 85-9. PMID 17586196 DOI: 10.1016/J.Jpeds.2007.03.002 |
0.35 |
|
| 2004 |
Quittell LM. Management of non-tuberculous mycobacteria in patients with cystic fibrosis. Paediatric Respiratory Reviews. 5: S217-9. PMID 14980274 DOI: 10.1016/S1526-0542(04)90041-3 |
0.37 |
|
| 1999 |
Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, Boucher R, Knowles MR. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. The New England Journal of Medicine. 341: 156-62. PMID 10403853 DOI: 10.1056/Nejm199907153410304 |
0.321 |
|
| 1995 |
Zar H, Saiman L, Quittell L, Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. The Journal of Pediatrics. 126: 230-3. PMID 7531240 DOI: 10.1016/S0022-3476(95)70549-X |
0.349 |
|
| Show low-probability matches. |
